Eagle Pharmaceuticals, Inc. (EGRX)
OTCMKTS
· Delayed Price · Currency is USD
1.490
+0.040 (2.76%)
Feb 21, 2025, 3:00 PM EST
Eagle Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 21, 2025 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Market Capitalization | 19 | 380 | 658 | 607 | 821 | 601 | Upgrade
|
| Market Cap Growth | -55.03% | -42.14% | 8.37% | -26.12% | 36.70% | -24.62% | Upgrade
|
| Enterprise Value | 312 | 430 | 590 | 556 | 748 | 554 | Upgrade
|
| Last Close Price | 1.49 | 29.23 | 50.92 | 46.57 | 60.08 | 40.29 | Upgrade
|
| PE Ratio | 1.63 | 10.67 | - | 50.61 | 57.39 | 18.83 | Upgrade
|
| Forward PE | - | 7.92 | 8.68 | 27.84 | 23.12 | 8.91 | Upgrade
|
| PS Ratio | 0.08 | 1.20 | 3.83 | 3.23 | 4.19 | 2.82 | Upgrade
|
| PB Ratio | 0.08 | 1.63 | 3.73 | 3.26 | 4.58 | 3.74 | Upgrade
|
| P/TBV Ratio | 2.78 | 6.13 | 5.22 | 4.55 | 6.63 | 5.84 | Upgrade
|
| P/FCF Ratio | - | 7.53 | 23.57 | 12.45 | 14.88 | 11.50 | Upgrade
|
| P/OCF Ratio | - | 7.50 | 23.30 | 12.26 | 14.67 | 11.47 | Upgrade
|
| EV/Sales Ratio | 1.21 | 1.36 | 3.44 | 2.96 | 3.82 | 2.60 | Upgrade
|
| EV/EBITDA Ratio | 5.00 | 3.82 | 90.30 | 15.24 | 29.56 | 11.05 | Upgrade
|
| EV/EBIT Ratio | 7.47 | 4.28 | 212.92 | 16.88 | 34.30 | 11.92 | Upgrade
|
| EV/FCF Ratio | - | 8.51 | 21.13 | 11.41 | 13.55 | 10.60 | Upgrade
|
| Debt / Equity Ratio | 0.29 | 0.28 | 0.15 | 0.18 | 0.22 | 0.28 | Upgrade
|
| Debt / EBITDA Ratio | 1.14 | 0.57 | 3.39 | 0.91 | 1.46 | 0.89 | Upgrade
|
| Debt / FCF Ratio | - | 1.30 | 0.96 | 0.70 | 0.70 | 0.85 | Upgrade
|
| Asset Turnover | 0.65 | 0.96 | 0.68 | 0.74 | 0.79 | 0.84 | Upgrade
|
| Inventory Turnover | 1.55 | 2.72 | 2.81 | 6.21 | 8.19 | 9.23 | Upgrade
|
| Quick Ratio | 1.51 | 1.15 | 1.87 | 4.05 | 4.06 | 3.66 | Upgrade
|
| Current Ratio | 2.16 | 1.70 | 2.32 | 4.36 | 4.62 | 4.13 | Upgrade
|
| Return on Equity (ROE) | 4.88% | 17.39% | -4.76% | 6.57% | 8.42% | 18.77% | Upgrade
|
| Return on Assets (ROA) | 6.63% | 19.03% | 0.68% | 8.11% | 5.53% | 11.42% | Upgrade
|
| Return on Capital (ROIC) | 8.46% | 24.99% | 0.82% | 9.40% | 6.45% | 13.44% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.11% | 34.05% | 1.54% | 15.32% | 10.11% | 23.36% | Upgrade
|
| Earnings Yield | 61.57% | 9.37% | -1.31% | 1.98% | 1.74% | 5.31% | Upgrade
|
| FCF Yield | -48.40% | 13.28% | 4.24% | 8.03% | 6.72% | 8.70% | Upgrade
|
| Buyback Yield / Dilution | -2.21% | -0.11% | 5.23% | 2.60% | 7.46% | 3.96% | Upgrade
|
| Total Shareholder Return | -2.21% | -0.11% | 5.23% | 2.60% | 7.46% | 3.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.